Event
|
||||||||||
| During this Symposium, a broad range of topics in advanced therapies will be discussed, including stem cell and gene therapy, biomaterials and tissue engineering as well as European Regulation for the development of Advanced Therapy Medicinal Products, among others therapies. | ||||||||||
| Thursday 28th of June 8:30 a.m OPENING CEREMONY 9:00 a.m CELL, GENE AND TISSUE ENGINEERING-BASED TECHNOLOGIES AND PLATFORMS Advanced Delivery Systems for Cell Therapies Robert Brown University College of London. UNITED KINGDOM. How many cells are needed for Tissue Engineering? C. James Kirkpatrick Johannes Gutenberg University, Mainz. GERMANY Reprogramming using the oocyte Jose Cibelli LARCel, Seville. SPAIN / Michigan State University. USA Vector development for gene therapy in immune related diseases Francisco Martin GENyO. Granada. SPAIN Platforms supporting research: bio-resources and genome sequencing Blanca Miranda Andalusian Biobank . Seville. SPAIN Javier Santoyo-Lopez Andalusian Human Genome Sequencing Centre. Seville. SPAIN 11:00 a.m. Coffee break 11:30 a.m. CURRENT CLINICAL APPLICATIONS AND FUTURE PERSPECTIVES WITH CELLS, GENES AND TISSUES Gene therapies for immunodeficiencies Adrian Thrasher University College of London. UNITED KINGDOM Neuroprotection and Cell Therapy in Parkinson’s Disease Jose Lopez Barneo IBIS, Seville. SPAIN Regenerative Medicine by Somatic Stem Cells: the Paradigm of Epithelial Stem Cells Michele DeLuca University of Modena and Reggio Emilia. ITALY Cell therapy in cardiovascular diseases Jose Suarez de Lezo Hospital Reina Sofia. Cordoba. SPAIN 13:30 p.m. Lunchtime 15:00 p.m. REGULATION FOR THE DEVELOPMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS (ATMPS) Introduction to the regulation of ATMPs Cesar Hernandez Agencia Española de Medicamentos y Productos Sanitarios (AEMPS). SPAIN Common issues in characterizing and manufacturing cell and gene-based therapies Maria Cristina Galli Committee for Advanced Therapies (CAT), EMA / Istituto Superiore di Sanitá. Roma, ITALY Challenges in non-clinical development of cell and gene-based medicinal products Beatriz Silva Committee for Advanced Therapies (CAT), EMA / INFARMED, Lisboa. PORTUGAL Risk-based approach applied to Advanced Therapy Medicinal Products Paula Salmikangas Committee for Advanced Therapies (CAT), EMA / Finnish Medicines Agency. Helsinki, FINLAND How the European countries are regulating the Hospital Exemption for non-industrially manufactured ATMPs? Ralf Sanzenbacher Paul-Ehrlich-Institut. Langen,GERMANY 17:00 p.m. Coffee break 17:30 p.m. INDUSTRY PRESENTATIONS 18:30 p.m. ORAL PRESENTATIONS Friday 29th of June: 8:30 a.m. ORAL PRESENTATIONS 9:30 a.m. Coffee break 10:00 a.m. EDUCATION AND TRAINING IN CELL AND GENE-BASED THERAPIES Strategies for teaching long-range inter-disciplinarity: Problems with integrated tissue engineering Robert Brown University College of London. UNITED KINGDOM Team training in Translational Medicine Jan Nolta Editor of Stem Cells Journal. University of California, Davis, USA Teaching cell-based technologies and tissue engineering in Medical Schools Miguel Alaminos University of Granada. SPAIN Beyond research and development, the necessity of training in manufacturing of ATMPs. Natividad Cuende Andalusian Initiative for Advanced Therapies. SPAIN 12:00 p.m. INTELLECTUAL PROPERTY ISSUES AND BUSINESS MODELS AROUND ATMPS Funding and Commercialization Strategies for Advanced Therapies Companies Gregory Bonfiglio Proteus Venture Partners, Palo Alto, California. USA Lessons learnt in the initial development of ATMPs in an academic setting Martino Introna Laboratorio di Terapia Cellulare e Genica "G. Lanzani".Ospedali Riuniti di Bergamo. ITALY Perspectives and future directions for the development of human Embryonic Stem Cell based Therapies. Jane S. Lebkowski Former Geron Corporation, California. USA Public-private partnership to develop tissue engineering approaches that can be useful in the clinic Rui L. Reis 3B’s Research Group. University of Minho. PORTUGAL Patentability of Stem Cells and Allied Technologies: Brüstle case Gustavo Fuster Hoffmann Eitle. Munich. GERMANY 14:00 p.m. CLOSING CEREMONY Follow this link http://gecoweb.gesintur.com/cgi.hrb?idexp=DNMAE to register and submit your abstract. |
||||||||||
|
Enlaces relacionados:
|
||||||||||
|
Permalink
|
||||||||||
|
|
||||||||||
